Skip to search formSkip to main contentSkip to account menu

CGS 13080

Known as: CGS-13080 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1993
Highly Cited
1993
Vascular relaxations are impaired in adult spontaneously hypertensive rats (SHRs) because of increased production of an… 
Highly Cited
1991
Highly Cited
1991
The endothelium releases substances controlling vascular tone and platelet function. We investigated mediators of endothelium… 
1989
1989
1 Administration of arachidonic acid caused dose‐dependent vasoconstriction in the isolated rat kidney perfused in situ with… 
1985
1985
Increase in thromboxane A2 (TXA2) generation has been proposed as a mechanism of dynamic vaso-occlusion and in vivo platelet… 
1984
1984
Abstract: CGS‐13080 is a new potent selective inhibitor of thromboxane synthetase. This study reports the results of a safety and… 
Highly Cited
1984
Highly Cited
1984
1 Platelet activating factor (Paf) (15–40 μg−1) kills male rabbits within 3 to 5 min. Intravenous injection of Paf at a dose of… 
1983
1983
A specific inhibitor of thromboxane A2 (TxA2) synthesis, CGS-13080, was studied during acute myocardial ischemia (MI) in cats. To…